November 9, 2022, 11:42 am EST
Emerging Leaders in BioTech and Pharmaceuticals
When the Nasdaq index tanked with massive layoffs announced, there were still emerging leaders who appeared. Therefore, keeping your eyes open and looking for investment opportunities is essential.
Obviously, it becomes much harder to pick the right stocks in the bear markets. But, focusing on emerging industries and groups should provide competitive edges because these stocks are already being noticed by smart investors who bought the uptrend.
More importantly, these emerging leaders need to be strong in the short-term (1 month), medium-term (3 months), and long-term (Year-To-Date) performance. In most cases, these stocks are making a fresh 52-week high now.
Here are 6 stocks in the biotech and pharmaceutical industries that we are paying attention to watching or already owned in our portfolio. Their performances (month,3-month, YTD) are shown after their symbols.
BioTech: 1-month, 3-month, YTD performance
- Amgen (AMGN): 29%, 17%, 31%
- Biogen (BIIB): 12%, 31%, 21%
- Gilead Sciences (GILD): 31%, 32%, 15%
Pharmaceuticals: 1-month, 3-month, YTD performance
- Merck (MRK): 18%, 16%, 35%
- Bristol-Myers Squibb (BMY): 16%, 8%, 30%
- Eli Lilly (LLY): 13%, 21%, 33%
Please take a look at their charts and study fundamentals for references.
